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ABSTRACT
Objectives: Mood instability is a clinically important
phenomenon but has received relatively little research
attention. The objective of this study was to assess the
impact of mood instability on clinical outcomes in a
large sample of people receiving secondary mental
healthcare.
Design: Observational study using an anonymised
electronic health record case register.
Setting: South London and Maudsley NHS Trust
(SLaM), a large provider of inpatient and community
mental healthcare in the UK.
Participants: 27 704 adults presenting to SLaM
between April 2006 and March 2013 with a psychotic,
affective or personality disorder.
Exposure: The presence of mood instability within
1 month of presentation, identified using natural
language processing (NLP).
Main outcome measures: The number of days
spent in hospital, frequency of hospital admission,
compulsory hospital admission and prescription of
antipsychotics or non-antipsychotic mood stabilisers
over a 5-year follow-up period.
Results: Mood instability was documented in 12.1%
of people presenting to mental healthcare services.
It was most frequently documented in people with
bipolar disorder (22.6%), but was common in people
with personality disorder (17.8%) and schizophrenia
(15.5%). It was associated with a greater number of
days spent in hospital (β coefficient 18.5, 95% CI 12.1
to 24.8), greater frequency of hospitalisation (incidence
rate ratio 1.95, 1.75 to 2.17), greater likelihood of
compulsory admission (OR 2.73, 2.34 to 3.19) and an
increased likelihood of prescription of antipsychotics
(2.03, 1.75 to 2.35) or non-antipsychotic mood
stabilisers (2.07, 1.77 to 2.41).
Conclusions: Mood instability occurs in a wide range
of mental disorders and is not limited to affective
disorders. It is generally associated with relatively poor
clinical outcomes. These findings suggest that
clinicians should screen for mood instability across all
common mental health disorders. The data also
suggest that targeted interventions for mood instability
may be useful in patients who do not have a formal
affective disorder.
INTRODUCTION
Mood instability is a common presenting
symptom for people with a wide variety of
mental disorders, with as many as 8 of 10
patients reporting some degree of mood
instability during assessment by adult com-
munity mental health teams.1 Although it
has principally been considered as a core
feature of borderline personality disorder,2
mood instability has also been described in
Strengths and limitations of this study
▪ This is the largest study (over 27 000 partici-
pants) to investigate the impact of mood instabil-
ity on clinical outcomes in people with mental
illness. The findings demonstrate that mood
instability occurs across a wide range of mental
disorders, rather than being limited to affective
disorders. It is also associated with poorer clinical
outcomes, independent of psychiatric diagnosis.
▪ This is the first study to use an automated infor-
mation extraction method to acquire data on
mood instability from electronic health records.
This approach maximises the representativeness
of everyday clinical practice and generalisability
to people receiving secondary mental healthcare.
▪ The findings are based on data recorded by clini-
cians delivering routine mental healthcare who
were not specifically seeking to elicit symptoms
of mood instability. It is therefore possible that
mood instability was not always recognised and
documented in electronic health records. If any-
thing, this would lead to an underestimate of its
prevalence.
▪ We collected data on mood instability within
1 month of presentation to mental healthcare
services, and did not assess severity or change
of mood instability symptoms over time.
However, even when restricting analysis to mood
instability symptoms experienced within 1 month
of presentation, the association with poorer clin-
ical outcomes was evident over a long period of
follow-up.
Patel R, et al. BMJ Open 2015;5:e007504. doi:10.1136/bmjopen-2014-007504 1
Open Access Research
group.bmj.com on May 22, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
bipolar disorder,3 depression4 and more recently psych-
otic disorders.5 Across a range of mental disorders,
mood instability has been associated with poor function-
ing, unhappiness and low self-esteem,6–8 increased use
of healthcare services9 and suicidality.10
A number of rating scales have been developed to
measure mood instability.11–15 However, these are not
routinely used in clinical practice and the presence of
mood instability can be overlooked, particularly as it is
sometimes perceived as being limited to affective disor-
ders.9 Most research on mood instability has involved
samples with a single disorder that may not be represen-
tative of the population of patients with mood instability
seen in everyday clinical practice.10
Clinical information is now widely recorded in the
form of electronic health records (EHRs). In the
present study, we used a novel information extraction
tool to identify the presence of mood instability in a
large sample of electronic records collected from indivi-
duals with a psychotic, affective or personality dis-
order.16 17 We then examined the relationship between
mood instability, mental disorder diagnosis and clinical
outcomes. We tested the hypothesis that mood instability
is present across a wide range of mental disorders at
presentation to mental health services, and is associated
with relatively poor clinical outcomes, as indexed by the
frequency and duration of mental health inpatient care.
METHODS
Participants
All individuals aged between 16 and 65 years who pre-
sented to the South London and Maudsley NHS
Foundation Trust (SLaM) between 1 April 2006 and 31
March 2013 and who received a diagnosis of schizophre-
nia and related disorders (ICD-10 F2x), bipolar affective
disorder (F30 and F31), psychotic depression (F32.3 and
F33.3), personality disorder (F60, F61), unipolar depres-
sion without psychosis (F32 and F33, excluding F32.3
and F33.3) or any other affective disorder (F34, F38,
F39) were included in the study. Applying these inclu-
sion criteria, a sample of 27 704 participants was
obtained. Of these, 3221 (11.6%) presented initially to
inpatient clinical services. Outcome data were collected
up to 31 March 2014. All participants were assessed for
outcomes within 1 year of the date of presenting to a
mental health service in SLaM. Participants with sufﬁ-
cient follow-up data were also assessed for outcomes
within 2 years (presenting between 1 April 2006 and 31
March 2012, n=24 848), 3 years (presenting between 1
April 2006 and 31 March 2011, n=21 188), 4 years (pre-
senting between 1 April 2006 and 31 March 2010,
n=17 130) and 5 years (presenting between 1 April 2006
and 31 March 2009, n=13 032).
Source of clinical data
The study was conducted using the SLaM Biomedical
Research Centre (BRC) Case Register.18 SLaM is a large
provider of mental healthcare in South London, cover-
ing a geographic catchment of approximately 1.2
million residents. Since April 2006, SLaM has used a
single electronic health record across all clinical services
known as the electronic Patient Journey System (ePJS).
The SLaM BRC Case Register extracts anonymised
clinical data from ePJS including structured ﬁelds (for
demographic information) and de-identiﬁed unstruc-
tured free text ﬁelds from case notes and correspond-
ence.18 A patient-led oversight committee provides
governance for all projects conducted using these
data.19 Healthcare professionals use these free text ﬁelds
to document clinical information during the course of
providing mental healthcare to patients. The clinical
information documented includes history, mental state
examination, diagnostic formulation and management
plan. Data for this study were obtained from these
sources of clinical data in the SLaM BRC Case Register
using Clinical Record Interactive Search (CRIS), a
bespoke database search and assembly tool which has
supported a range of studies using this data set.20–25
Mood instability measurement development
The natural language processing (NLP) software
package TextHunter17 26 was used to extract documenta-
tion of mood instability from unstructured free text
ﬁelds of clinical assessments and correspondence in the
SLaM BRC Case Register. On the basis of the rationale
that a varied lexicon is used to label and describe symp-
tomatology in healthcare records,27 three NLP applica-
tions were developed for each of the following affective
construct terms: mood, affect and emotion. In order to
ascertain the concept of instability, a free text search was
conducted on the three keywords (mood, affect and
emotion) to identify the most frequently used modiﬁer
words up to two words on either side of the keyword.
The search results were manually reviewed by TL, RP
and MT and modiﬁer words relevant to the concept of
instability (including common misspellings) were
selected for inclusion in a gazetteer for each of the
three NLP applications (see online supplementary table
S1). This approach was used in order to develop NLP
applications that extracted clinical information relevant
to the data on which they were applied.26 Although not
present in the initial search results, the words ‘instabil-
ity’, ‘dysfunction’ and ‘irregular’ were also included in
all three applications since they are commonly used in
the literature to describe mood instability.15
All sentences in the SLaM BRC Case Register contain-
ing the keywords and modiﬁer words (see online
supplementary table S1) were extracted and used as a
basis to develop NLP applications to identify the con-
structs of instability of mood, affect and emotion. For
each application, a human annotator (TL) classiﬁed the
presence or absence of the construct in around 300 sen-
tences to generate a reference data set for subsequent
precision testing. The reference data set of each applica-
tion was also annotated by RP in order to test the inter-
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annotator agreement for the classiﬁcation of sentences.
Online supplementary table S2 shows the breakdown of
annotations and the inter-annotator agreement for each
of the three NLP applications. Percentage agreement
was above 90% and Cohen’s κ at least 0.80 for all appli-
cations indicating good inter-annotator agreement in
determining each construct. A supervised machine
learning approach with active learning was used to iden-
tify sentences containing the constructs of interest.
Further sentences were classiﬁed by a human annotator
(TL) to generate a training data set on which a
‘bag-of-words’ support vector machine learning algo-
rithm was applied (with one round of active learning) in
order to develop NLP applications to identify each con-
struct.28 Each application was tested against the refer-
ence data set to obtain baseline precision (positive
predictive value) and recall (sensitivity) statistics at a sen-
tence level (see online supplementary ﬁgure S1).29 As
patients with mood instability had multiple sentences in
their clinical record which were relevant to the con-
structs in this study, the NLP applications were devel-
oped to maximise the precision of each application in
order to reduce the likelihood of false-positive results. A
machine learning probability threshold was therefore
applied to each application to obtain a per sentence pre-
cision (positive predictive value) of at least 90%. This
value was determined as the optimum for precision
based on previous studies evaluating NLP applications to
extract symptom data in mental health.26 Online supple-
mentary table S3 shows the precision statistics for each
of the three NLP applications. Baseline precision
exceeded 80% for all applications. Applying probability
thresholds to achieve at least 90% precision resulted in a
small reduction in recall for all applications.
Once developed, the applications were then applied
to the BRC Case Register and the output of all three
were combined to generate a binary variable for each
participant deﬁned as any documentation of instability
of mood, affect or emotion within 1 month of presenta-
tion to SLaM. This variable was used to assess the preva-
lence of mood instability within the study population
and also as the predictor for regression analyses on clin-
ical outcomes described subsequently.
Clinical outcome measures and covariates
The primary outcome was number of days spent in a
psychiatric hospital during the follow-up period. This
outcome measure was chosen because the increased
duration of hospital stay represents a measure of illness
severity as well as a signiﬁcant impact to individuals, their
family and carers and mental healthcare services.30
Secondary outcomes included any compulsory hospital
admission (under the UK Mental Health Act), frequency
of hospital admissions, antipsychotic prescription and
non-antipsychotic mood stabiliser prescription during the
follow-up period. For the purposes of this study, antipsy-
chotics were deﬁned as any licensed antipsychotic medica-
tion listed in section 4.2.1 or 4.2.2 of the British National
Formulary (BNF)31 and non-antipsychotic mood stabilisers
were deﬁned as valproate, carbamazepine, lamotrigine or
lithium.32 The following variables were extracted as covari-
ates for multivariable analyses: age, gender, ethnicity,
marital status and diagnosis. All covariate data obtained
were those closest to the date of presenting to SLaM.
Ethnicity was recorded according to categories deﬁned by
the UKOfﬁce for National Statistics.33
Statistical analysis
The data were analysed using Stata (V.12.0).34 Descriptive
statistics for predictor, covariate and outcome variables
were obtained as the mean and variance for number of
hospital admissions, mean and SDs for number of days
spent in hospital and as frequencies and percentages for
all other variables.
The association of mood instability with number of
inpatient days was assessed using multiple linear regres-
sion. Owing to overdispersion, association of mood
instability with number of hospital admissions was ana-
lysed using multivariable negative binomial regression.
Associations with compulsory hospital admission, anti-
psychotic prescription and non-antipsychotic mood sta-
biliser prescription were assessed using multivariable
binary logistic regression. Reference groups for covari-
ates in regression analyses were deﬁned as those with
the greatest prevalence for each variable. A sensitivity
analysis was performed to assess the impact of missing
data for marital status which affected 4120 people in the
sample.
RESULTS
Prevalence and distribution of mood instability
The overall prevalence in our sample of recorded mood
instability within 1 month of clinical presentation was
12.1% (table 1). Mood instability was most likely to be
present in people who were younger (16–25 years) and
female, and less likely in those who were single and who
presented with unipolar depression. The strongest diag-
nostic association of mood instability was seen among
those presenting with bipolar disorder. Mood instability
was also associated with personality disorder and schizo-
phrenia but to a lesser degree than with bipolar dis-
order. A sensitivity analysis which only included
participants with no missing covariate data (see online
supplementary table S4) did not reveal any meaningful
differences.
Hospital admission and pharmacological outcomes
Mood instability was associated with a greater number of
days spent in hospital, a greater likelihood of compulsory
admission to hospital and increased frequency of hospital
admission (table 2) up to 5 years following clinical presen-
tation. After adjusting for age, gender, ethnicity, marital
status and diagnosis in multivariable regression analyses,
mood instability remained a signiﬁcant predictor of these
hospitalisation outcomes (table 3). There was an excess of
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zero values for the number of hospital admissions during
the follow-up period. However, despite a signiﬁcant Vuong
test result, ﬁtting a zero-inﬂated negative binomial regres-
sion model (see online supplementary table S5) resulted
in only a slight reduction in incident rate ratios compared
with standard negative binomial regression (table 3).
Mood instability was also associated with an increased risk
of antipsychotic prescription and non-antipsychotic mood
stabiliser prescription (table 4). Much of the increased risk
of antipsychotic prescription occurred within the ﬁrst year
of follow-up while the cumulative risk of non-antipsychotic
mood stabiliser prescription increased steadily over the
period of 5-year follow-up. These associations remained
after adjusting for demographic factors in multivariable
logistic regression analyses (table 5).
DISCUSSION
To the best of our knowledge, this is the ﬁrst study to
investigate mood instability as documented in the health
records of people with mental illness. We demonstrate
that it is possible to identify the presence of mood
instability in electronic health records using automated
NLP methods. Using a data-driven approach which was
tailored to the clinical records in the SLaM BRC Case
Register, we developed applications with a high degree
of accuracy and inter-rater reliability. As a result, we were
able to implement rapid extraction of data on mood
instability from a very large sample of patients (27 704 in
our study) that would have been logistically unfeasible
by either a manual review of clinical records or through
prospective data collection.
As hypothesised, we found that mood instability is fre-
quently documented in people across a range of differ-
ent mental disorders (12.1% in our sample). Although
this is comparable to the overall prevalence found in
other studies (13.2% in Black et al;35 13.9% in Marwaha
et al9), these were measured in general populations,
whereas our participants were deﬁned by their use of
mental health services. Prevalences of mood instability
between 49.2% and 83.8% have been reported in other
studies,1 5 9 10 but these ﬁndings were based on patient
self-report measures: in this study, mood instability was
measured by its written presence in clinical records. As
speciﬁc rating scales to measure mood instability are not
routinely applied in clinical practice, the lower preva-
lence seen in our study could indicate that symptoms of
mood instability are not always elicited or documented
in electronic health records, and when they are docu-
mented because they are deemed to be clinically rele-
vant to the patient’s care. However, it is possible that if
clinicians had speciﬁcally sought to identify the presence
of mood instability using screening questionnaires, the
prevalence may have been higher than that elicited
Table 2 Hospital admission outcomes among individuals with and without documented mood instability
Mean number of inpatient
days (SD)
Compulsory
admission (%)
Mean number of
admissions (variance)
Follow-up
period (months)
Number in
sample
History
of mood
instability
No history
of mood
instability
History
of mood
instability
No history
of mood
instability
History
of mood
instability
No history
of mood
instability
0–12 27 704 25.1 (50.7) 8.6 (35.9) 28.5 7.4 0.63 (0.71) 0.21 (0.28)
0–24 24 848 32.7 (77.3) 13.9 (60.3) 29.3 9.0 0.72 (1.10) 0.26 (0.47)
0–36 21 188 38.6 (97.5) 18.0 (79.4) 30.0 9.9 0.82 (1.48) 0.31 (0.67)
0–48 17 130 45.5 (119.5) 21.7 (92.4) 30.1 10.9 0.90 (2.02) 0.37 (0.93)
0–60 13 032 53.1 (138.6) 25.5 (104.9) 30.5 12.0 0.98 (2.44) 0.43 (1.19)
Table 3 Multivariable analyses of relationship between mood instability and frequency of hospital admission, likelihood of
compulsory hospital admission and mean number of days spent in hospital up to 5 years following presentation to mental
health services
Follow-up
period
(months)
Number
in sample
Number of days
spent in hospital*
β Coefficient (95% CI),
p value
Compulsory
hospital admission†
OR (95% CI), p value
Number of admissions
to hospital‡
Incidence rate ratio
(95% CI), p value
0–12 27 704 13.4 (12.1 to 14.8), <0.001 4.55 (4.11 to 5.04), <0.001 2.62 (2.47 to 2.77), <0.001
0–24 24 848 13.9 (11.4 to 16.3), <0.001 3.77 (3.39 to 4.20), <0.001 2.33 (2.18 to 2.49), <0.001
0–36 21 188 13.5 (10.0 to 17.1), <0.001 3.39 (3.01 to 3.81), <0.001 2.17 (2.01 to 2.35), <0.001
0–48 17 130 15.9 (11.2 to 20.7), <0.001 3.02 (2.64 to 3.45), <0.001 2.07 (1.89 to 2.26), <0.001
0–60 13 032 18.5 (12.1 to 24.8), <0.001 2.73 (2.34 to 3.19), <0.001 1.95 (1.75 to 2.17), <0.001
Results adjusted for age, gender, ethnicity, marital status and diagnosis.
*Multiple linear regression.
†Multivariable logistic regression.
‡Multivariable negative binomial regression.
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using NLP on routinely recorded clinical data.
Furthermore, the documentation of symptoms may have
been biased by the underlying diagnosis. This could be
investigated further in future studies comparing NLP
methods with standardised questionnaires for eliciting
mood instability and mental disorder diagnosis.
Patients with documented mood instability were more
likely to be young, female and single, largely consistent
with ﬁndings from a previous study investigating the
prevalence of mood instability in a large adult popula-
tion.9 Mood instability was particularly associated with a
diagnosis of bipolar affective disorder. This ﬁnding cor-
roborates previous research which has indicated that
mood instability is a key factor in bipolar disorder, as dis-
tinct from episodes of mania and depression.36 37
However, mood instability was also prevalent in other dis-
orders (such as schizophrenia, psychotic depression and
personality disorders), suggesting that it occurs in a
range of mental disorders, consistent with recent ﬁnd-
ings from British National Survey data.5
The data supported the hypothesis that mood instabil-
ity is associated with poorer clinical outcomes and
increased use of healthcare services. Those with a
recorded instance of mood instability within 1 month of
presentation to mental health services were admitted to
hospital more frequently and were at greater risk of being
compulsorily detained under the UK Mental Health Act
over the 5-year follow-up period. Furthermore, people
with mood instability were likely to spend a signiﬁcantly
greater time in hospital (around 13 additional days
within the ﬁrst year following presentation). The
increased risk of hospitalisation outcomes was greatest in
the ﬁrst year following presentation, indicating the sig-
niﬁcant impact of mood instability on initial clinical out-
comes after presenting to mental health services,
independent of psychiatric diagnosis. Extensive use of
inpatient resources has been well observed in patients
with mood instability,9 and this represents morbidity
to individuals and cost to healthcare services.38
Consequently, direct treatment of this symptom, irre-
spective of a patient’s working diagnosis, could have con-
siderable health economic beneﬁts.
The presence of mood instability was also associated
with an increased likelihood of antipsychotic and non-
antipsychotic mood stabiliser prescription. Our data
suggest that the greatest rate of antipsychotic prescribing
occurred within 1 year of follow-up while the cumulative
risk of non-antipsychotic mood stabiliser prescriptions
progressively increased over 5 years of follow-up.
Multivariable regression analysis demonstrated that these
associations were also independent of psychiatric diagno-
sis. This suggests that mood instability was associated
with early antipsychotic treatment, consistent with their
utility as rapid and effective mood stabilisers,39 40
followed by the subsequent use of lithium or anticonvul-
sants to provide longer term mood stabilisation.
However, as our ﬁndings were drawn from observational
data, it is not possible to infer an aetiological association
Table 4 Cumulative percentage of patients with and without documented mood instability who were subsequently prescribed
an antipsychotic or non-antipsychotic mood stabiliser
Antipsychotic prescription (%)
Non-antipsychotic mood
stabiliser prescription (%)
Follow-up
period (months)
Number in
sample
History of mood
instability
No history of
mood instability
History of mood
instability
No history of
mood instability
0–12 27 704 52.5 27.8 19.8 8.0
0–24 24 848 53.7 30.7 22.0 9.5
0–36 21 188 54.8 32.5 24.0 10.6
0–48 17 130 55.7 34.3 25.1 12.0
0–60 13 032 56.1 35.8 27.6 12.7
Table 5 Multivariable logistic regression analyses of relationship between mood instability and likelihood of antipsychotic and
non-antipsychotic mood stabiliser prescription up to 5 years following presentation to mental health services
Follow-up
period (months)
Number in
sample
Antipsychotic prescription
OR (95% CI), p value
Non-antipsychotic mood
stabiliser prescription
OR (95% CI), p value
0–12 27 704 2.71 (2.48 to 2.96), <0.001 2.26 (2.03 to 2.52), <0.001
0–24 24 848 2.40 (2.18 to 2.64), <0.001 2.09 (1.86 to 2.33), <0.001
0–36 21 188 2.24 (2.01 to 2.50), <0.001 2.06 (1.82 to 2.32), <0.001
0–48 17 130 2.14 (1.89 to 2.43), <0.001 1.90 (1.66 to 2.17), <0.001
0–60 13 032 2.03 (1.75 to 2.35), <0.001 2.07 (1.77 to 2.41), <0.001
Antipsychotic: any licensed antipsychotic medication listed in section 4.2.1 of the British National Formulary (BNF).
Non-antipsychotic mood stabiliser: valproate, carbamazepine, lamotrigine or lithium.
Results adjusted for age, gender, ethnicity, marital status and diagnosis.
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between mood instability and pharmacotherapy. It is pos-
sible that this ﬁnding represents the choice of pharma-
cotherapy in relation to the licensed indication for the
underlying disorder being treated rather than speciﬁc-
ally to treat symptoms of mood instability.
A major strength of the study was the substantial size
of the sample. Participants were gathered from the case
register of a large mental healthcare provider and
included based on contact with services within a given
period, rather than being specially selected for research
purposes. This approach maximised the generalisability
of our ﬁndings since the sample was more representative
of everyday clinical practice. Another strength was the
use of a novel automated information extraction
method to reliably and accurately ascertain the presence
of documented mood instability, thereby reducing any
potential bias which may occur through a manual review
of case records by multiple investigators.
There were some limitations to this study which could
be addressed in future research. As the data were drawn
from routine clinical records, it was found that some par-
ticipants had missing data for marital status. However, a
sensitivity analysis including only participants with full
covariate data did not reveal any meaningful differences
in results. There were also other covariates of interest
which were not comprehensively documented in elec-
tronic health records (and consequently could not be
analysed) including the presence and severity of manic
and psychotic symptoms, history of deliberate self-harm,
age of onset of illness and drug and alcohol misuse.
A further limitation of using routine clinical records
was the impact of loss to follow-up. Whereas in a pro-
spective observational or interventional study there is a
standardised schedule to obtain follow-up data from par-
ticipants, this is not the case for data from routine clin-
ical care where contact with mental health services is
determined by a complex interaction of patient and
service related factors. It is possible that patients were
discharged from mental health services during the
period of the study for a number of reasons including
improvement in symptoms (ie, planned discharge to
primary care), disengagement from mental health ser-
vices and moving outside the catchment area of SLaM.
It was not possible to obtain data on the reason for dis-
charge in our data set to see if there was an association
with mood instability which could have biased outcomes.
Further work is needed to establish the impact of mood
instability on level of engagement with mental health
services.
It was decided to limit observations of mood instability
to within 1 month of contact with services. It may be
that patients develop or display this problem further
into their treatment, meaning that some instances of
mood instability may have been overlooked. However, it
was noteworthy that even restricting the ascertainment
of mood instability to this time window resulted in sub-
stantial associations with poorer clinical outcomes over
the period of follow-up of up to 5 years. Also, in order to
balance project scope and feasibility, the sample was
limited to patients with psychotic and affective disorders
which have been shown to be relevant to mood instabil-
ity in previous studies.1 2 4 5 However, mood instability is
also known to occur in some disorders not included in
this study (eg, attention deﬁcit hyperactivity disorder).41
Future work could expand on other diagnostic categor-
ies to assess the impact of mood instability in other
mental disorders.
The deﬁnition and measurement of mood instability
in our study conceptualised the construct as a binary
variable (present or absent) and did not collect data on
the frequency or severity of the instability, which may be
important to predict future illness course.42 43 It also
combined data from three separate applications which
focused on instability related to distinct affective terms
(mood, affect and emotion). This method was chosen
based on ﬁndings from previous studies which indicate
that these three terms may be used interchangeably
despite representing subtly different constructs.5 9 15
This approach raises questions about the construct valid-
ity of the mood instability measure since it is not certain
that the examples identiﬁed by each tool are clinically
or phenomenologically equivalent. Nonetheless, analysis
of the large quantity of data obtained using this study’s
measure of mood instability led to meaningful and clin-
ically relevant ﬁndings, indicating that it is a robust
research tool which targets an important construct in its
own right, despite its potential heterogeneity.
CONCLUSION
Taken together, our ﬁndings suggest that mood instabil-
ity is associated with poorer clinical outcomes and
increased use of antipsychotic and non-antipsychotic
mood stabiliser therapy, regardless of the mental dis-
order with which an individual initially presents. Our
study suggests that clinicians should consider screening
for the presence of mood instability on a routine basis
and that it should be given more attention, irrespective
of an individual’s underlying psychiatric diagnosis.
These ﬁndings have important implications for clinical
practice and highlight the need for interventional
studies across a range of mental disorders to better
understand which pharmacological and psychosocial
interventions are most successful in reducing the impact
of mood instability.
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